Join
Live feed
·
INSIDERFilingvia Quantisnow
Cara Therapeutics Inc. logo

PRESIDENT AND CEO Posner Christopher sold $1,452 worth of shares (4,149 units at $0.35), decreasing direct ownership by 2% to 172,436 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CARA· Cara Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CARA (Cara Therapeutics Inc.) and more on Quantisnow.